Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Mansoor, US
Arshad Mansoor, Oak Ridge, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20100073969 | PHOTOVOLTAIC INTEGRATED VARIABLE FREQUENCY DRIVE - A photovoltaic (PV) integrated variable frequency drive system having a variable frequency drive and an energy source. The variable frequency drive having a back end inverter, a DC bus electrically connected to the back end inverter, and an active front end electrically connected to the DC bus to facilitate bi-directional power flow to and from a power grid. The energy source being electrically connected to the DC bus. | 03-25-2010 |
| 20100085065 | PASSIVE AGENT SYSTEM IMPEDANCE MONITORING STATION AND METHOD - This invention relates to a hybrid passive agent system impedance monitoring station and method. The method of monitoring impedance of an electrical system includes the steps of providing an impedance monitoring station adapted to test and monitor system impedance, solving for system impedance in a time domain, solving for system impedance in a frequency domain, and determining a time domain driving point impedance and a frequency domain driving point impedance to identify the impedance of the system. | 04-08-2010 |
George A. Mansoor, Rahway, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120095019 | METHODS AND FORMULATIONS OF TREATING THROMBOSIS WITH BETRIXABAN AND A P-GLYCOPROTEIN INHIBITOR - This invention is directed to methods of inhibiting coagulation or treating thrombosis using a factor Xa inhibitor and a P-glycoprotein (Pgp) inhibitor. The invention is also directed to formulations used in the methods. | 04-19-2012 |
Mehryar Mansoor, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110077949 | MICROPAYMENTS AGGREGATION - Various methods, apparatus, and systems are disclosed for improved micropayment arrangements that allow for versatile and efficient micropayments aggregation and distribution of funds. In accordance with one embodiment, a method of aggregating micropayments includes registering a plurality of seller accounts, each including content to be sold, and associating the content with a micropayment aggregation method, including pre-paid aggregation, post-paid aggregation, and time-delayed aggregation. The method further includes then charging a buyer account for purchases of content based on different micropayment aggregation methods associated with the content. | 03-31-2011 |
| 20120084177 | LOCATION BASED TRANSACTIONS - A user's location is determined by location information communicated by a user device, such as a smart phone. Merchants near the user location are determined and selected. Merchant payment information is transmitted to the user device so that the user can easily make a payment to the merchant through the user device. Merchant offerings may also be sent to the user device for purchase and subsequent payment, where the merchant offerings may be specifically selected for the user. | 04-05-2012 |
Shariq Mansoor, Dublin, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110047204 | SYSTEM AND METHOD FOR FACILITATING SECURE INTEGRATION AND COMMUNICATION OF CLOUD SERVICES AND ENTERPRISE APPLICATIONS - Methods, apparatuses, and computer program products are disclosed for facilitating integration and communication of cloud services and enterprise applications. The disclosed aspects include identifying a port opened by an integration device within an on-premise system to communicate with a cloud system. A persistent connection with the cloud system is maintained via this port so as to provide on-premise access to the cloud system via the integration device, including access to at least one different device within the on-premise system. Aspects for facilitating a bidirectional communication of distributed objects between an on-premise system and a cloud system are also disclosed. Here, on-premise objects residing within the on-premise system are abstracted, and requests from the cloud system to invoke the on-premise objects are facilitated. Similarly, cloud objects residing within the cloud system are abstracted, and requests from the on-premise system to invoke the cloud objects are facilitated. | 02-24-2011 |
Umar Faruk Mansoor, Framingham, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080226618 | HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS - This invention relates to compounds of the Formula (I), | 09-18-2008 |
| 20090170875 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): | 07-02-2009 |
| 20100179141 | NOVEL JNK INHIBITORS - Disclosed are compounds of the formula (I) wherein X is N or CH, and Y is N or CR | 07-15-2010 |
| 20100298314 | NOVEL JNK INHIBITORS - Disclosed are substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines and imidazo[1,2-d]triazines compounds of the formula: (1.0) Also disclosed are methods for treating JNK1 and ERK mediated diseases using the compounds of formula 1.0. | 11-25-2010 |
| 20110123435 | COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY - The present invention relates to compounds of Formula (I), below, (wherein X, R1, R2, R3, p, E, ring A, and ring B are as defined herein). The present invention also relates to compositions (including pharmaceutically acceptable compositions) comprising these compounds, alone and in combination with one or more additional therapeutic agents, and to methods for their use in inhibiting KSP kinesin activity, and for treating cellular proliferative diseases or disorders associated with KSP kinesin activity. Formula I | 05-26-2011 |
| 20110150757 | COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY - The present invention relates to compounds of Formula (I), below, (wherein R1, R2, R3, R27, R28, R29, p, E, ring A, and ring B are as defined herein). The present invention also relates to compositions (including pharmaceutically acceptable compositions) comprising these compounds, alone and in combination with one or more additional therapeutic agents, and to methods for their use in inhibiting KSP kinesin activity, and for treating cellular proliferative diseases or disorders associated with KSP kinesin activity. | 06-23-2011 |
| 20110171172 | COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY - The present invention relates to compounds of Formula (I), below, (wherein R | 07-14-2011 |
| 20110212078 | SYNTHESIS AND USE OF HETEROCYCLIC ANTIBACTERIAL AGENTS - This invention relates to compounds of the following Formula (I); or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which is useful for the treatment of diseases or conditions mediated by LpxC. | 09-01-2011 |
Umar Faruk Mansoor, Farmingham, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110212080 | UREA DERIVATIVES AS ANTIBACTERIAL AGENTS - This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which is useful for the treatment of diseases or conditions mediated by LpxC. | 09-01-2011 |